The wind of change – PCSK9 inhibitors in hypolipidemic treatment. The Polish perspective
Introduction and aim. Cardiovascular diseases are the main cause of mortality in the world. One of the alterable risk factors of ischaemic heart disease is dyslipidemia. Discovery and usage of a new group of drugs - PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors lead to a decrease...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Kazimierz Wielki University
2023-09-01
|
| coleção: | Journal of Education, Health and Sport |
| Assuntos: | |
| Acesso em linha: | https://apcz.umk.pl/JEHS/article/view/45486 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|